Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Rheumatoid Arthritis

Free Subscription Articles published in Arthritis Res Ther Retrieve available abstracts of 166 articles: HTML format

Single Articles

September 2025
1. NATALUCCI F, Triaille C, Sapart E, Dierckx S, et al
   Evolution from early to difficult-to-treat rheumatoid arthritis: incidence and risk factors in the ERA uclouvain Brussels cohort.
   Arthritis Res Ther. 2025;27:182.
   PubMed     Abstract available
   
   
   
2. ZHAO X, Sun X, Wu F, Huang K, et al
   Longitudinal patterns of obesity index changes and risk of incident rheumatoid arthritis: evidence from a population-based cohort.
   Arthritis Res Ther. 2025;27:186.
   PubMed     Abstract available
   
   
   
3. JIA Y, Li R, Huang L, Wu X, et al
   The Glycolysis-HIF-1alpha axis induces IL-1beta of macrophages in rheumatoid arthritis.
   Arthritis Res Ther. 2025;27:180.
   PubMed     Abstract available
   
   
   
4. FATIMA T, Zhang Y, Vasileiadis GK, Rawshani A, et al
   Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
   Arthritis Res Ther. 2025;27:177.
   PubMed    
   
   
   
5. BILBERG A, Bjersing J, Borjesson M, Sivertsson J, et al
   High-intensity exercise improves multidimensional fatigue and health-related quality of life in rheumatoid arthritis: a randomized controlled study.
   Arthritis Res Ther. 2025;27:176.
   PubMed     Abstract available
   
   
   
6. SHI Z, Ding Y, Dong X, Li G, et al
   The diagnostic value and clinical relevance of salivary gland ultrasound in patients with highly suspected Sjogren's Disease: a prospective monocentric study.
   Arthritis Res Ther. 2025;27:175.
   PubMed     Abstract available
   
   
   August 2025
7. MACHADO CRL, Choi E, Perumal NB, Benschop RJ, et al
   Regulation of fibroblast-like synoviocyte function by cadherin 6 in rheumatoid arthritis.
   Arthritis Res Ther. 2025;27:172.
   PubMed     Abstract available
   
   
   
8. LIU X, Fang F, Duan H, Wu C, et al
   KLF11 alleviates rheumatoid arthritis by regulating M1 macrophage polarization via downregulation of YAP1 expression.
   Arthritis Res Ther. 2025;27:171.
   PubMed     Abstract available
   
   
   
9. QIAO Z, Meng Q, Xiao B, Long Y, et al
   Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway.
   Arthritis Res Ther. 2025;27:167.
   PubMed     Abstract available
   
   
   
10. MUCIENTES A, Nunez GMM, Mena-Vazquez N, Lisbona-Montanez JM, et al
    Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study.
    Arthritis Res Ther. 2025;27:165.
    PubMed     Abstract available
    
    
    
11. TRIANTAFYLLIAS K, Bach M, Bogel S, Muthuraman M, et al
    Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjogren's: the SICARD cohort study.
    Arthritis Res Ther. 2025;27:164.
    PubMed     Abstract available
    
    
    July 2025
12. JOHANSSON L, Pratesi F, Errante F, Pacini L, et al
    Cytokines, chemokines and antibodies against histone-3/4 citrullinated peptides in rheumatoid arthritis patients with pulmonary fibrosis.
    Arthritis Res Ther. 2025;27:160.
    PubMed     Abstract available
    
    
    
13. ZHENG S, Zhou Z, Du G, Chen Q, et al
    The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:159.
    PubMed     Abstract available
    
    
    
14. FATIMA T, Zhang Y, Vasileiadis GK, Rawshani A, et al
    Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
    Arthritis Res Ther. 2025;27:156.
    PubMed     Abstract available
    
    
    
15. KACZMARCZYK B, Conde C, Gonzalez A
    Meta-analysis identifies the major impact of patient classification on the ACPA association with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Arthritis Res Ther. 2025;27:151.
    PubMed     Abstract available
    
    
    
16. RODRIGUEZ-MERLOS P, Cabrera-Alarcon JL, Ruiz-Esquide V, Chacur CA, et al
    Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold.
    Arthritis Res Ther. 2025;27:153.
    PubMed     Abstract available
    
    
    
17. BIRCK MG, Boivin J, Yan L, Carrier N, et al
    Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis.
    Arthritis Res Ther. 2025;27:150.
    PubMed     Abstract available
    
    
    
18. KALLIOLIAS GD, Basdra EK, Papavassiliou AG
    Killing arthritogenic fibroblast-like synoviocytes: an example using cytotoxic aptamers binding nucleolin.
    Arthritis Res Ther. 2025;27:148.
    PubMed     Abstract available
    
    
    
19. YOSHIDA T, Murotani Y, Murata K, Imai H, et al
    Roles of JAK-STAT signaling and granulocyte-macrophage colony-stimulating factor in the development of osteitis and bone microstructure changes in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:143.
    PubMed     Abstract available
    
    
    
20. LIU Y, Xin Y, Wang W, Feng W, et al
    The association between metabolic syndrome severity and frailty risk in patients with rheumatoid arthritis: a cross-sectional study.
    Arthritis Res Ther. 2025;27:145.
    PubMed     Abstract available
    
    
    
21. WU T, Gu L, Shi B, Wu Y, et al
    nCD64 index as a new early predictive biomarker for macrophage activation syndrome in adult-onset still's disease.
    Arthritis Res Ther. 2025;27:144.
    PubMed     Abstract available
    
    
    
22. VEALE JD, Gorman A, Veale DJ, Fearon U, et al
    Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures.
    Arthritis Res Ther. 2025;27:147.
    PubMed     Abstract available
    
    
    
23. YUE G, Yan Y, Zeng X, Liu R, et al
    Association between rheumatoid arthritis and kidney stones: A cross-sectional study of NHANES 2007-2020.
    Arthritis Res Ther. 2025;27:141.
    PubMed     Abstract available
    
    
    
24. MAHER A, Hegazy MT, Algarf TM, Abdul-Aziz MA, et al
    Sicca manifestations and lymphoproliferation in hepatitis C virus: effects of direct acting antiviral therapy on dryness and B-cell activity compared to Sjogren's disease.
    Arthritis Res Ther. 2025;27:139.
    PubMed     Abstract available
    
    
    
25. BIERSTEKER R, Athanasiadou A, van der Meulen S, van Wesemael TJ, et al
    Insights into the detection of AMPA cross-reactivity: comparing cyclic peptide- to protein-based assays.
    Arthritis Res Ther. 2025;27:138.
    PubMed     Abstract available
    
    
    
26. WU R, Li B, Su R, Liu X, et al
    Serum tryptophan-kynurenine metabolites served as biomarkers of disease activity in rheumatoid arthritis and linked to immune imbalance.
    Arthritis Res Ther. 2025;27:136.
    PubMed     Abstract available
    
    
    
27. NOACK M, Miossec P
    IFNgamma production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:134.
    PubMed     Abstract available
    
    
    
28. BAEK IW, Kim HA, Park KS, Kim KJ, et al
    Targeting neutrophil-driven inflammation in adult-onset still's disease: molecular insights from gene expression profiles.
    Arthritis Res Ther. 2025;27:130.
    PubMed     Abstract available
    
    
    
29. MARTINEZ-RAMOS S, Rafael-Vidal C, Marty J, Malvar-Fernandez B, et al
    Semaphorin4B is elevated in rheumatoid arthritis and enhances the inflammatory phenotype of macrophages and fibroblast-like synoviocytes.
    Arthritis Res Ther. 2025;27:132.
    PubMed     Abstract available
    
    
    
30. KURAMOTO T, Sakuraba K, Kai K, Terada K, et al
    Risk factors affecting the vital prognosis in patients with rheumatoid arthritis after primary cervical spine surgery: a retrospective study.
    Arthritis Res Ther. 2025;27:131.
    PubMed     Abstract available
    
    
    June 2025
31. GOSSEC L, Patel J, Kadakia A, Fang S, et al
    Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study.
    Arthritis Res Ther. 2025;27:123.
    PubMed     Abstract available
    
    
    May 2025
32. WANG Z, Lan T, Jiao Y, Wang X, et al
    Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites.
    Arthritis Res Ther. 2025;27:111.
    PubMed     Abstract available
    
    
    
33. CURTIS JR, Conrad DM, Krueger WS, Gara AP, et al
    Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster.
    Arthritis Res Ther. 2025;27:108.
    PubMed     Abstract available
    
    
    
34. BAKER MC, Nagy D, Tamang S, Horvath-Puho E, et al
    Vagotomy and the incidence of rheumatoid arthritis and osteoarthritis: a Danish register-based study.
    Arthritis Res Ther. 2025;27:106.
    PubMed     Abstract available
    
    
    
35. VELA-CASASEMPERE P, Otero-Varela L, Gomez Sabater S, Cano Alameda R, et al
    Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naive patients with rheumatoid arthritis: Data from BIOBADASER III registry.
    Arthritis Res Ther. 2025;27:103.
    PubMed     Abstract available
    
    
    
36. VAN WESEMAEL TJ, Morton FR, Heutz JW, Maurits MP, et al
    Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:101.
    PubMed     Abstract available
    
    
    April 2025
37. KONG H, Qiao Y, Qi D, Zhao S, et al
    circ_0002970 promotes fibroblast-like synoviocytes invasion and the inflammatory response through Hippo/YAP signaling to induce CTGF/CCN1 expression in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:97.
    PubMed     Abstract available
    
    
    
38. HU C, Wang L, Huang J, Shang Y, et al
    Regional brain function study in patients with primary Sjogren's syndrome.
    Arthritis Res Ther. 2025;27:93.
    PubMed     Abstract available
    
    
    
39. O'BYRNE AM, Bolt JW, van Ansenwoude CMJ, van der Heijde M, et al
    Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients.
    Arthritis Res Ther. 2025;27:94.
    PubMed     Abstract available
    
    
    
40. HASHIMOTO T, Tsuboi K, Abe T, Yoshikawa T, et al
    Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study.
    Arthritis Res Ther. 2025;27:91.
    PubMed     Abstract available
    
    
    
41. MARIN J, Bourgoin P, Saverna N, Cartagena C, et al
    The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab.
    Arthritis Res Ther. 2025;27:86.
    PubMed     Abstract available
    
    
    
42. CHEN WS, Hsu HC, Lin TM, Chang YS, et al
    Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjogren syndrome patients on glucocorticoids: a nationwide population-based cohort study.
    Arthritis Res Ther. 2025;27:88.
    PubMed     Abstract available
    
    
    
43. OSTOR A, Feist E, Sidiropoulos P, Avouac J, et al
    Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study.
    Arthritis Res Ther. 2025;27:84.
    PubMed     Abstract available
    
    
    
44. WU W, Yang W, Deng B, Li H, et al
    Concomitant Sjogren's disease in patients with NMOSD: impacts on neurologic disease severity and recurrence.
    Arthritis Res Ther. 2025;27:78.
    PubMed     Abstract available
    
    
    
45. KHOROSHUN K, Bantel C, Hoffmann F, Jobski K, et al
    Methotrexate-related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance.
    Arthritis Res Ther. 2025;27:80.
    PubMed     Abstract available
    
    
    
46. ASAI S, Kojima T, Ishikawa H, Miyake N, et al
    Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.
    Arthritis Res Ther. 2025;27:82.
    PubMed     Abstract available
    
    
    
47. SHAO Y, Yang Y, Yang X, Xu Z, et al
    A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers.
    Arthritis Res Ther. 2025;27:75.
    PubMed     Abstract available
    
    
    March 2025
48. GOODWIN GL, Marin AC, Walker JV, Hobbs C, et al
    Using in vivo calcium imaging to examine joint neuron spontaneous activity and home cage analysis to monitor activity changes in mouse models of arthritis.
    Arthritis Res Ther. 2025;27:67.
    PubMed     Abstract available
    
    
    
49. FUJII T, Murata K, Kohjitani H, Onishi A, et al
    Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort.
    Arthritis Res Ther. 2025;27:65.
    PubMed     Abstract available
    
    
    
50. YANG X, Guo Q, Feng T, Lu Q, et al
    Correction: IL13Ralpha1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes.
    Arthritis Res Ther. 2025;27:64.
    PubMed    
    
    
    
51. WANG H, Yuan T, Wang J, Li D, et al
    Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis.
    Arthritis Res Ther. 2025;27:54.
    PubMed     Abstract available
    
    
    
52. ONISHI A, Tanaka M, Fujii T, Murata K, et al
    Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
    Arthritis Res Ther. 2025;27:52.
    PubMed     Abstract available
    
    
    February 2025
53. WU J, Feng R, Wang R, He J, et al
    Impact of disease duration on systemic clinical profile in Sjogren's syndrome.
    Arthritis Res Ther. 2025;27:39.
    PubMed     Abstract available
    
    
    
54. ASGARI N, Ghaemi EA, Tavasoli S, Aghaei M, et al
    Exploring the association between Mycobacterium avium subspecies paratuberculosis infection and rheumatoid arthritis: an immunological perspective.
    Arthritis Res Ther. 2025;27:36.
    PubMed     Abstract available
    
    
    
55. WANG X, Sun L, An Z, Li C, et al
    CXCL7 enhances RANKL-induced osteoclastogenesis via the activation of ERK/NFATc1 signaling pathway in inflammatory arthritis.
    Arthritis Res Ther. 2025;27:34.
    PubMed     Abstract available
    
    
    
56. NOMURA M, Sugihara T, Baba H, Hosoya T, et al
    Long-term outcome of a treat-to-target strategy in late-onset rheumatoid arthritis with chronic lung disease: 5-year results of a prospective observational study.
    Arthritis Res Ther. 2025;27:22.
    PubMed     Abstract available
    
    
    
57. ALTEN R, Behar C, Merckaert P, Afari E, et al
    Predicting abatacept retention using machine learning.
    Arthritis Res Ther. 2025;27:20.
    PubMed     Abstract available
    
    
    January 2025
58. TRIANTAFYLLIAS K, Alhaddad M, Schwarting A, Balaklytska V, et al
    Diagnostic performance of optical spectral transmission compared to magnetic resonance imaging in patients with inflammatory arthritis.
    Arthritis Res Ther. 2025;27:17.
    PubMed     Abstract available
    
    
    
59. SONG MK, Gu MF, Liu L, He LJ, et al
    GPIHBP1 increase accounts for rheumatic arthritis-related hypotriglyceridemia by facilitating lipids uptake of white adipose tissues.
    Arthritis Res Ther. 2025;27:16.
    PubMed     Abstract available
    
    
    
60. LIU H, Li Q, Chen Y, Dong M, et al
    Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK/STAT signaling pathway.
    Arthritis Res Ther. 2025;27:12.
    PubMed     Abstract available
    
    
    
61. FLORIS A, Angioni MM, Fadda M, Naitza MR, et al
    The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis.
    Arthritis Res Ther. 2025;27:9.
    PubMed     Abstract available
    
    
    
62. ZHOU Z, Wu S, Li Y, Shao P, et al
    Inhibition of macrophage polarization and pyroptosis in collagen-induced arthritis through MSC-exo and ginsenoside Rh2.
    Arthritis Res Ther. 2025;27:6.
    PubMed     Abstract available
    
    
    
63. LUCIANO N, Barone E, Brunetta E, D'Isanto A, et al
    Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender.
    Arthritis Res Ther. 2025;27:2.
    PubMed     Abstract available
    
    
    
64. WU JY, Zhang JY, Xia WQ, Kang YN, et al
    Predicting autoimmune thyroiditis in primary Sjogren's syndrome patients using a random forest classifier: a retrospective study.
    Arthritis Res Ther. 2025;27:1.
    PubMed     Abstract available
    
    
    December 2024
65. ARONSSON M, Bergman S, Lindqvist E, Andersson MLE, et al
    High leptin levels in blood are associated with chronic widespread pain in rheumatoid arthritis.
    Arthritis Res Ther. 2024;26:228.
    PubMed     Abstract available
    
    
    
66. AGNIHOTRI P, Saquib M, Joshi L, Malik S, et al
    Integrative metabolomic-proteomic analysis uncovers a new therapeutic approach in targeting rheumatoid arthritis.
    Arthritis Res Ther. 2024;26:227.
    PubMed     Abstract available
    
    
    
67. WANG P, Wang D, Sui J, Liu S, et al
    The comprehensive relationship between combined anti-inflammatory and healthy diets and all-cause mortality in rheumatoid arthritis: results from NHANES 2003-2018.
    Arthritis Res Ther. 2024;26:226.
    PubMed     Abstract available
    
    
    
68. MAHARAJ N, Uppada DR, Reddy N, Reddy P, et al
    Comparing immunogenicity and safety following transition from reference rituximab to biosimilar rituximab (DRL_RI) in patients with rheumatoid arthritis: a randomized, double-blind, phase 3 study.
    Arthritis Res Ther. 2024;26:225.
    PubMed     Abstract available
    
    
    
69. ZHANG X, Liao Z, Chen Y, Lu H, et al
    A non-invasive model for diagnosis of primary Sjogren's disease based on salivary biomarkers, serum autoantibodies, and Schirmer's test.
    Arthritis Res Ther. 2024;26:217.
    PubMed     Abstract available
    
    
    
70. DIXIT T, Vaidya A, Ravindran S
    Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenies of rheumatoid arthritis.
    Arthritis Res Ther. 2024;26:216.
    PubMed     Abstract available
    
    
    
71. DOS SANTOS GG, Jimenez-Andrade JM, Munoz-Islas E, Candanedo-Quiroz ME, et al
    Role of TLR4 activation and signaling in bone remodeling, and afferent sprouting in serum transfer arthritis.
    Arthritis Res Ther. 2024;26:212.
    PubMed     Abstract available
    
    
    
72. RAMIEN R, Rudi T, Alten R, Krause A, et al
    Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT.
    Arthritis Res Ther. 2024;26:209.
    PubMed     Abstract available
    
    
    
73. WEI J, Li J, Li T, Xu T, et al
    Genetically predicted metabolite mediates the causal relationship between immune cells and autoimmune diseases.
    Arthritis Res Ther. 2024;26:207.
    PubMed     Abstract available
    
    
    November 2024
74. D'ONOFRIO B, De Stefano L, Bozzalla Cassione E, Morandi V, et al
    Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat.
    Arthritis Res Ther. 2024;26:192.
    PubMed     Abstract available
    
    
    
75. KLIMAK M, Cimino A, Lenz KL, Springer LE, et al
    Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery.
    Arthritis Res Ther. 2024;26:190.
    PubMed     Abstract available
    
    
    
76. ZHU X, Long W, Zhang J, Jian C, et al
    Integrated multi-omics revealed that dysregulated lipid metabolism played an important role in RA patients with metabolic diseases.
    Arthritis Res Ther. 2024;26:188.
    PubMed     Abstract available
    
    
    October 2024
77. LI JB, Liu PC, Chen L, Wu R, et al
    Infiltrations of plasma cells in synovium predict inadequate response to Adalimumab in Rheumatoid Arthritis patients.
    Arthritis Res Ther. 2024;26:186.
    PubMed     Abstract available
    
    
    
78. BERGSTROM B, Sellden T, Bollmann M, Svensson MND, et al
    Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling.
    Arthritis Res Ther. 2024;26:178.
    PubMed     Abstract available
    
    
    
79. GEORGOPOULOS V, Smith S, McWilliams DF, Ferguson E, et al
    Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain.
    Arthritis Res Ther. 2024;26:175.
    PubMed     Abstract available
    
    
    September 2024
80. DING L, Park DH, Gao B, Wu L, et al
    Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in rheumatoid arthritis (RA).
    Arthritis Res Ther. 2024;26:173.
    PubMed     Abstract available
    
    
    
81. RUSCITTI P, Currado D, Rivellese F, Vomero M, et al
    Diminished expression of the ubiquitin-proteasome system in early treatment-naive patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort.
    Arthritis Res Ther. 2024;26:171.
    PubMed     Abstract available
    
    
    
82. LACKNER A, Dreo B, Hermann J, Zenz S, et al
    Patients' recollection about the onset of Sjogren's disease - a mixed methods study on the patients' perspective.
    Arthritis Res Ther. 2024;26:169.
    PubMed     Abstract available
    
    
    
83. TRIANTAFYLLIAS K, Altamimi KK, Schederecker F, Schwarting A, et al
    Increased predictive value of optical spectral transmission in early rheumatoid arthritis through use of patient-adjusted cut-off scores.
    Arthritis Res Ther. 2024;26:165.
    PubMed     Abstract available
    
    
    
84. CINCINELLI G, Maioli G, Posio C, Favalli EG, et al
    Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients.
    Arthritis Res Ther. 2024;26:161.
    PubMed     Abstract available
    
    
    
85. LENG X, Leszczynski P, Jeka S, Liu S, et al
    A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to met
    Arthritis Res Ther. 2024;26:157.
    PubMed     Abstract available
    
    
    August 2024
86. HETLAND ML, Strangfeld A, Bonfanti G, Soudis D, et al
    Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib.
    Arthritis Res Ther. 2024;26:153.
    PubMed     Abstract available
    
    
    
87. ZENG Y, Liu R, Li S, Wei J, et al
    Analysis of risk factors and development of a nomogram prediction model for renal tubular acidosis in primary Sjogren syndrome patients.
    Arthritis Res Ther. 2024;26:151.
    PubMed     Abstract available
    
    
    
88. NATALUCCI F, Triaille C, Van Mullem C, Sokolova T, et al
    Inclusion of fibrinoid necrosis increases the accuracy of synovial tissue assessment in predicting response to methotrexate: analysis of the UCLouvain Brussels ERA Cohort.
    Arthritis Res Ther. 2024;26:150.
    PubMed     Abstract available
    
    
    July 2024
89. VAN VOLLENHOVEN R, Strand V, Takeuchi T, Chavez N, et al
    Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial.
    Arthritis Res Ther. 2024;26:143.
    PubMed     Abstract available
    
    
    
90. OCHI S, Sonomoto K, Nakayamada S, Tanaka Y, et al
    Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry.
    Arthritis Res Ther. 2024;26:140.
    PubMed     Abstract available
    
    
    
91. KIEFER D, Soltani M, Damirchi P, Kiltz U, et al
    Prevalence and location of inflammatory and structural lesions in patients with rheumatoid arthritis and radiographic axial spondyloarthritis with chronic neck pain evaluated by magnetic resonance imaging.
    Arthritis Res Ther. 2024;26:138.
    PubMed     Abstract available
    
    
    
92. SONG YJ, Kim H, Cho SK, Kim HW, et al
    Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study.
    Arthritis Res Ther. 2024;26:137.
    PubMed     Abstract available
    
    
    
93. KALLIOLIAS GD, Papavassiliou AG
    Stabilizing the integrity of intestinal barrier to control arthritis.
    Arthritis Res Ther. 2024;26:135.
    PubMed     Abstract available
    
    
    
94. LUO J, Zhang J, Ju B, Wang Y, et al
    JAK inhibitors attenuate hyperactivation of nonswitched memory B cells in rheumatoid arthritis patients in remission.
    Arthritis Res Ther. 2024;26:134.
    PubMed     Abstract available
    
    
    
95. KOLLER-SMITH L, Mehdi A, March L, Tooth L, et al
    A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases.
    Arthritis Res Ther. 2024;26:133.
    PubMed     Abstract available
    
    
    
96. SU J, Hu W, Ding Y, Zhang P, et al
    Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study.
    Arthritis Res Ther. 2024;26:130.
    PubMed     Abstract available
    
    
    
97. HERNANDEZ-DIAZ M, Rodriguez-Gonzalez D, Heras-Recuero E, Gomez-Bernal F, et al
    The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis.
    Arthritis Res Ther. 2024;26:127.
    PubMed     Abstract available
    
    
    June 2024
98. LIAO KP, Rist P, Giles J, Santacroce L, et al
    Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial.
    Arthritis Res Ther. 2024;26:123.
    PubMed     Abstract available
    
    
    
99. CUBUK C, Lau R, Cutillas P, Rajeeve V, et al
    Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes.
    Arthritis Res Ther. 2024;26:120.
    PubMed     Abstract available
    
    
    
100. COHEN S, Beebe JS, Chindalore V, Guan S, et al
     A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with syst
     Arthritis Res Ther. 2024;26:117.
     PubMed     Abstract available
     
     
     May 2024
101. QIAN H, Deng C, Chen S, Zhang X, et al
     Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:103.
     PubMed     Abstract available
     
     
     
102. CHEN Z, Li X, Shi H, Huang Y, et al
     Causal relationship between rheumatoid arthritis and bronchiectasis: a bidirectional mendelian randomization study.
     Arthritis Res Ther. 2024;26:104.
     PubMed     Abstract available
     
     
     
103. CHEN X, Zhu L, Wu H
     The role of M1/M2 macrophage polarization in primary Sjogren's syndrome.
     Arthritis Res Ther. 2024;26:101.
     PubMed     Abstract available
     
     
     
104. LEHMANN J, Giaglis S, Kyburz D, Daoudlarian D, et al
     Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:97.
     PubMed     Abstract available
     
     
     
105. ITO Y, Ichikawa Y, Murashima S, Sakuma H, et al
     Rheumatoid arthritis disease activity significantly impacts on the severity of interstitial lung disease.
     Arthritis Res Ther. 2024;26:95.
     PubMed     Abstract available
     
     
     April 2024
106. YAMADA Z, Muraoka S, Kawazoe M, Hirose W, et al
     Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.
     Arthritis Res Ther. 2024;26:87.
     PubMed     Abstract available
     
     
     March 2024
107. POLLASTRO S, Musters A, Balzaretti G, Niewold I, et al
     Sensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:70.
     PubMed     Abstract available
     
     
     
108. CHRIST L, Kissling S, Finckh A, Fisher BA, et al
     Concomitant Sjogren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort.
     Arthritis Res Ther. 2024;26:68.
     PubMed     Abstract available
     
     
     
109. CHANG L, Zheng Z, Zhou Y, Liu K, et al
     B cell receptor repertoire analysis in primary Sjogren's syndrome salivary glands identifies repertoire features associated with clinical activity.
     Arthritis Res Ther. 2024;26:62.
     PubMed     Abstract available
     
     
     
110. LIU J, Idborg H, Korotkova M, Lend K, et al
     Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:61.
     PubMed     Abstract available
     
     
     February 2024
111. ZHANG J, Luo Y, Wu B, Huang X, et al
     Identifying functional dysregulation of NOD2 variant Q902K in patients with Yao syndrome.
     Arthritis Res Ther. 2024;26:58.
     PubMed     Abstract available
     
     
     
112. CALVO-GUTIERREZ J, Lopez-Medina C, Otero-Varela L, Escudero-Contreras A, et al
     Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.
     Arthritis Res Ther. 2024;26:57.
     PubMed     Abstract available
     
     
     
113. LI G, Fang Y, Xu N, Ding Y, et al
     Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes.
     Arthritis Res Ther. 2024;26:56.
     PubMed     Abstract available
     
     
     
114. O'NEIL LJ, Anaparti V, Winter T, Smolik I, et al
     Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for developing rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:51.
     PubMed     Abstract available
     
     
     
115. UKALOVIC D, Leeb BF, Rintelen B, Eichbauer-Sturm G, et al
     Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioReg.
     Arthritis Res Ther. 2024;26:44.
     PubMed     Abstract available
     
     
     
116. MALEKI-FISCHBACH M, Kastsianok L, Koslow M, Chan ED, et al
     Manifestations and management of Sjogren's disease.
     Arthritis Res Ther. 2024;26:43.
     PubMed     Abstract available
     
     
     
117. HOLLANDER NKD, Boeren AMP, van der Helm-van Mil AHM, van Steenbergen HW, et al
     Patients with obesity have more inflamed joints and higher CRP levels during the disease course in ACPA-positive RA but not in ACPA-negative RA.
     Arthritis Res Ther. 2024;26:42.
     PubMed     Abstract available
     
     
     January 2024
118. ZHANG J, Cai H, Sun W, Wu W, et al
     Endoplasmic reticulum aminopeptidase 2 regulates CD4(+) T cells pyroptosis in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:36.
     PubMed     Abstract available
     
     
     
119. XU M, Chen H, Tan T, Xie K, et al
     Exploring the causal association between rheumatoid arthritis and the risk of cervical cancer: a two-sample Mendelian randomization study.
     Arthritis Res Ther. 2024;26:35.
     PubMed     Abstract available
     
     
     
120. STRAUBE J, Bukhari S, Lerrer S, Winchester RJ, et al
     PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis.
     Arthritis Res Ther. 2024;26:32.
     PubMed     Abstract available
     
     
     
121. HONG J, Cheng H, Wang P, Wu Y, et al
     CXCL9 may serve as a potential biomarker for primary Sjogren's syndrome with extra-glandular manifestations.
     Arthritis Res Ther. 2024;26:26.
     PubMed     Abstract available
     
     
     
122. THORARINSDOTTIR K, McGrath S, Forslind K, Agelii ML, et al
     Cartilage destruction in early rheumatoid arthritis patients correlates with CD21(-/low) double-negative B cells.
     Arthritis Res Ther. 2024;26:23.
     PubMed     Abstract available
     
     
     
123. WU R, Wang D, Cheng L, Su R, et al
     Impaired immune tolerance mediated by reduced Tfr cells in rheumatoid arthritis linked to gut microbiota dysbiosis and altered metabolites.
     Arthritis Res Ther. 2024;26:21.
     PubMed     Abstract available
     
     
     
124. CHEN K, Tao H, Zhu P, Chu M, et al
     ADAM8 silencing suppresses the migration and invasion of fibroblast-like synoviocytes via FSCN1/MAPK cascade in osteoarthritis.
     Arthritis Res Ther. 2024;26:20.
     PubMed     Abstract available
     
     
     
125. AZUAGA AB, Cuervo A, Celis R, Frade-Sosa B, et al
     Synovial tissue features associated with poor prognosis in inflammatory arthritis.
     Arthritis Res Ther. 2024;26:18.
     PubMed     Abstract available
     
     
     
126. FUJII T, Murata K, Onizawa H, Onishi A, et al
     Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort.
     Arthritis Res Ther. 2024;26:16.
     PubMed     Abstract available
     
     
     
127. DI MUZIO C, Di Cola I, Shariat Panahi A, Ursini F, et al
     The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study.
     Arthritis Res Ther. 2024;26:14.
     PubMed     Abstract available
     
     
     
128. DUAN L, Li S, Li H, Shi Y, et al
     Causality between rheumatoid arthritis and the risk of cognitive impairment: a Mendelian randomization study.
     Arthritis Res Ther. 2024;26:5.
     PubMed     Abstract available
     
     
     
129. LEE HI, Ahn MJ, Yoo JK, Ahn SH, et al
     Exosome-mediated delivery of super-repressor IkappaBalpha alleviates inflammation and joint damages in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:2.
     PubMed     Abstract available
     
     
     
130. LUO Q, Zhu J, Wang S, Fu P, et al
     Decreased expression of NAT10 in peripheral blood mononuclear cells from new-onset ankylosing spondylitis and its clinical significance.
     Arthritis Res Ther. 2024;26:7.
     PubMed     Abstract available
     
     
     
131. IWASAKI T, Watanabe R, Ito H, Fujii T, et al
     Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis.
     Arthritis Res Ther. 2024;26:1.
     PubMed     Abstract available
     
     
     
132. THUDIUM CS, Frederiksen P, Karsdal MA, Bay-Jensen AC, et al
     Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab.
     Arthritis Res Ther. 2024;26:3.
     PubMed     Abstract available
     
     
     
133. KIM D, Heo Y, Kim M, Suminda GGD, et al
     Inhibitory effects of Acanthopanax sessiliflorus Harms extract on the etiology of rheumatoid arthritis in a collagen-induced arthritis mouse model.
     Arthritis Res Ther. 2024;26:11.
     PubMed     Abstract available
     
     
     December 2023
134. JIAN C, Wei L, Wu T, Li S, et al
     Comprehensive multi-omics analysis reveals the core role of glycerophospholipid metabolism in rheumatoid arthritis development.
     Arthritis Res Ther. 2023;25:246.
     PubMed     Abstract available
     
     
     
135. HUANG Y, Peng Y, Li H, Li C, et al
     Wilforine inhibits rheumatoid arthritis pathology through the Wnt11/beta-catenin signaling pathway axis.
     Arthritis Res Ther. 2023;25:243.
     PubMed     Abstract available
     
     
     
136. ZHANG X, He X, Zhang M, Wu T, et al
     Efficient delivery of the lncRNA LEF1-AS1 through the antibody LAIR-1 (CD305)-modified Zn-Adenine targets articular inflammation to enhance the treatment of rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:238.
     PubMed     Abstract available
     
     
     
137. LI J, Cui J, Wu L, Liu YB, et al
     Machine learning and molecular subtype analyses provide insights into PANoptosis-associated genes in rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:233.
     PubMed     Abstract available
     
     
     November 2023
138. RYDHOLM M, Sharma A, Jacobsson L, Turesson C, et al
     The relation between synovitis of individual finger joints and grip force over the first 5 years in early rheumatoid arthritis - a cohort study.
     Arthritis Res Ther. 2023;25:231.
     PubMed     Abstract available
     
     
     
139. SAINZ L, Riera P, Moya P, Bernal S, et al
     Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:226.
     PubMed     Abstract available
     
     
     
140. SOLOMON DH, Guan H, Johansson FD, Santacroce L, et al
     Assessing clusters of comorbidities in rheumatoid arthritis: a machine learning approach.
     Arthritis Res Ther. 2023;25:224.
     PubMed     Abstract available
     
     
     
141. KIELBASSA K, Van der Weele L, Voskuyl AE, de Vries N, et al
     Differential expression pattern of Bcl-2 family members in B and T cells in systemic lupus erythematosus and rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:225.
     PubMed     Abstract available
     
     
     
142. WARD MM, Madanchi N, Yazdanyar A, Shah NR, et al
     Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review.
     Arthritis Res Ther. 2023;25:222.
     PubMed     Abstract available
     
     
     
143. ZHOU D, Xie J, Wang J, Zong J, et al
     Establishment of a differential diagnosis method and an online prediction platform for AOSD and sepsis based on gradient boosting decision trees algorithm.
     Arthritis Res Ther. 2023;25:220.
     PubMed     Abstract available
     
     
     
144. YANG M, Su Y, Xu K, Xie J, et al
     Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study.
     Arthritis Res Ther. 2023;25:219.
     PubMed     Abstract available
     
     
     
145. GUO D, Pan H, Lu X, Chen Z, et al
     Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/beta-catenin pathway.
     Arthritis Res Ther. 2023;25:217.
     PubMed     Abstract available
     
     
     
146. TESSER J, Gul A, Olech E, Oelke K, et al
     Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials.
     Arthritis Res Ther. 2023;25:214.
     PubMed     Abstract available
     
     
     October 2023
147. BATHON JM, Centola M, Liu X, Jin Z, et al
     Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis.
     Arthritis Res Ther. 2023;25:213.
     PubMed     Abstract available
     
     
     
148. BRUCKNER S, Capria VM, Zeno B, Leblebicioglu B, et al
     The therapeutic effects of gingival mesenchymal stem cells and their exosomes in a chimeric model of rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:211.
     PubMed     Abstract available
     
     
     
149. RUYSSEN-WITRAND A, Guernec G, Dupont J, Lapuyade D, et al
     Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity.
     Arthritis Res Ther. 2023;25:207.
     PubMed     Abstract available
     
     
     
150. XUE L, Wang B, Li X, Zhu J, et al
     Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:201.
     PubMed     Abstract available
     
     
     
151. RODRIGUEZ-MARTINEZ L, Garcia-Moreno C, Perez-Pampin E, Gomara MJ, et al
     Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression.
     Arthritis Res Ther. 2023;25:192.
     PubMed     Abstract available
     
     
     
152. WANG Z, Zhang J, An F, Zhang J, et al
     The mechanism of dendritic cell-T cell crosstalk in rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:193.
     PubMed     Abstract available
     
     
     
153. WRIGHT M, Smed MK, Nelson JL, Olsen J, et al
     Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy.
     Arthritis Res Ther. 2023;25:191.
     PubMed     Abstract available
     
     
     
154. LI X, Wang Y, Chen Z, Ruan M, et al
     Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment.
     Arthritis Res Ther. 2023;25:188.
     PubMed     Abstract available
     
     
     
155. ZHANG F, Cheng T, Zhang SX
     Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:187.
     PubMed     Abstract available
     
     
     
156. HUANG Y, Xue Q, Chang J, Wang Y, et al
     M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.
     Arthritis Res Ther. 2023;25:189.
     PubMed     Abstract available
     
     
     September 2023
157. CIUREA A, Distler O, Kwok K, Jo H, et al
     Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start.
     Arthritis Res Ther. 2023;25:185.
     PubMed     Abstract available
     
     
     
158. BESSETTE L, Haraoui B, Rampakakis E, Dembowy J, et al
     Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept.
     Arthritis Res Ther. 2023;25:183.
     PubMed     Abstract available
     
     
     
159. RAMIREZ-PEREZ S, Vekariya R, Gautam S, Reyes-Perez IV, et al
     MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients.
     Arthritis Res Ther. 2023;25:180.
     PubMed     Abstract available
     
     
     
160. OKITA Y, Hirano T, Wang B, Nakashima Y, et al
     Automatic evaluation of atlantoaxial subluxation in rheumatoid arthritis by a deep learning model.
     Arthritis Res Ther. 2023;25:181.
     PubMed     Abstract available
     
     
     
161. AHMED S, Mahony CB, Torres A, Murillo-Saich J, et al
     Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis.
     Arthritis Res Ther. 2023;25:176.
     PubMed     Abstract available
     
     
     
162. LI M, Shi Y, Zhao J, Wang Q, et al
     Identification of potential susceptibility genes in patients with primary Sjogren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing.
     Arthritis Res Ther. 2023;25:175.
     PubMed     Abstract available
     
     
     
163. JUNG JY, Lee E, Kim JW, Suh CH, et al
     Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry.
     Arthritis Res Ther. 2023;25:174.
     PubMed     Abstract available
     
     
     
164. JIA Y, Yao P, Li J, Wei X, et al
     Causal associations of Sjogren's syndrome with cancers: a two-sample Mendelian randomization study.
     Arthritis Res Ther. 2023;25:171.
     PubMed     Abstract available
     
     
     
165. PAPPAS DA, O'Brien J, Guo L, Shan Y, et al
     Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry.
     Arthritis Res Ther. 2023;25:166.
     PubMed     Abstract available
     
     
     
166. SHAO Y, Zhang H, Shi Q, Wang Y, et al
     Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease.
     Arthritis Res Ther. 2023;25:159.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.